Pharma, Payers Study highlights role of doctor conflicts of interest in Medicare spending on Mallinckrodt drug Acthar By Alaric DeArment
Kaiser, Pharma The potential for conflict of interest when health policy experts also serve on the boards of pharma companies By Sarah Jane Tribble, Kaiser Health News
Policy, Kaiser CMS documents highlight Rep. Tom Price’s Congressional record on special medical interests By Christina Jewett and Marisa Taylor
Devices & Diagnostics Pharma, device firms kill conflict of interest rule, win accelerated approval By
MedCity Influencers Sen. Grassley: How does FDA define doctor ‘conflict of interest?’ By MassDevice Staff
News Institute of Medicine to docs: Get rid of conflicts — MedCity morning read, April 29 By Mary Vanac
Pharma Case Western Reserve University dramatically expands conflict-of-interest policy By Chris Seper
BioPharma, Pharma Many doctors writing clinical practice guidelines receive undisclosed industry payments, study finds By Alaric DeArment
Top Story, Hospitals, Devices & Diagnostics Hospitals look for ways to limit role of medical device salespeople in the operating room By Sandra G. Boodman
